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Preoperative splenic artery embolization for massive splenomegaly has been shown to
reduce intraoperative hemorrhage during splenectomy. We describe a case of tumor lysis
syndrome after proximal splenic artery embolization in a patient with advanced mantle
cell lymphoma and splenic involvement. The patient presented initially with hyper-
kalemia two days after embolization that worsened during splenectomy. He was stabi-
lized, but developed laboratory tumor lysis syndrome with renal failure and expired. High
clinical suspicion of tumor lysis syndrome in this setting is advised. Treatment must be
started early to avoid serious renal injury and death. Lastly, same day splenectomy and
embolization should be considered to decrease the likelihood of developing tumor lysis
syndrome.
Copyright © 2016, the Authors. Published by Elsevier Inc. under copyright license from the
University of Washington. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Open splenectomy for massive splenomegaly (drained splenic
weight, >1000 g) is associated with a high morbidity and
mortality [1,2]. Themost common complication of this surgery
is uncontrolled intraoperative hemorrhage [2]. Preoperative
splenic artery embolization has been shown to reduce intra-
operative bleeding and has been widely used for both open
and laparoscopic techniques [1,2]. There are 2 major modal-
ities of splenic artery embolization: proximal splenic artery
embolization, defined as embolization of themain trunk of thelared that no competing i
(F.J. Gortes).
blished by Elsevier Inc. u
ND license (http://creativsplenic artery; and distal splenic artery embolization, defined
as embolization of one ormore of the terminal branches of the
splenic artery [3]. Proximal splenic artery embolization has a
lower risk of splenic infarction compared with distal splenic
artery embolization because of the extensive collateral
arteries (eg, short gastric arteries) supplying the spleen [4].
However,most patientswithmassive splenomegaly are late in
their disease course, conferring a high rate of hematologic
complications (eg, anemia, thrombocytopenia, leukopenia,
and pancytopenia) [5]. Here, we present a case of acute tumor
lysis syndrome after proximal splenic artery embolization.nterests exist.
nder copyright license from the University of Washington. This is
ecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1 e A 58-year-old man with massive splenomegaly.
Axial contrast-enhanced CT of the abdomen showing
splenomegaly with compression of the left renal
parenchyma (arrow).
Fig. 2 e (A) Preembolization angiogram showing tip of
catheter proximal to the first branch of the splenic artery
(arrow). (B) Postembolization angiogram showing coil
(arrow) at main trunk of splenic artery with minimal distal
flow.
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Our patient is a 58-year-old man with a medical history of
mantle cell lymphoma refractory to chemotherapy with 8
months of worsening splenomegaly and thrombocytopenia.
He presented to the emergency department with a 5-day
history of persistent left upper quadrant abdominal pain.
The spleen was palpable on examination, and measured 23
 22  10 cm3 on computed tomography scan (Fig. 1), with
an approximate volume of 2964.8 cm3 using the splenic
volume formula [6]. On the morning of the procedure, the
laboratory values were significant for leukocyte count of
11.6/mm3, platelet count of 46,000/mL, potassium of 3.0
mEq/L, phosphate of 1.5 mg/dL, blood urea nitrogen (BUN)
of 37 mg/dL, and creatinine (Cr) of 1.27 mg/dL. Pretreatment
lactate dehydrogenase and uric acid were not available.
Proximal splenic artery embolization was performed with
an Amplatzer plug (St. Jude Medical, St. Paul, AK) and coils.
Additional coils were necessary because of persistent for-
ward flow 15 minutes after plug deployment (Fig. 2A and B).
Two days after the procedure, the patient’s leukocyte
count was 32.5/mm3, potassium was 6.1 mEq/L, phosphate
was 3.6 mg/dL, BUN was 28 mg/dL, and Cr was 1.52 mg/dL.
Calcium gluconate 1 g intravenous was administered for the
hyperkalemia. The patient then underwent an open sple-
nectomy. One liter of ascites was seen and suctioned on
entering the peritoneal cavity. The spleen was then
exposed, revealing multiple areas of infarction. The hyper-
kalemia continued to worsen throughout the surgery,
prompting the anesthesia team to transfuse insulin,
glucose, and bicarbonate. Potassium rose to a maximum of
7.8 mEq/L intraoperatively before stabilizing at 5.0 mEq/L
the following day. Of note, pathology of the spleen was
significant for a gross weight of 3880 g, and diffuse efface-
ment of normal parenchyma by neoplastic cells.Postoperatively, the patient remained intubated on
continuous positive airway pressure support for 24 hours and
was extubated with no neurologic sequelae. Immediate
postoperative course was complicated by nonoliguric renal
failure confirmed by rising BUN and Cr. Renal function
improved with maintenance D5W at 150cc/H and albumin
boluses as needed. Leukocytosis also improved but began to
rise again on the fourth postoperative day. The patient also
developed concomitant massive ascites and bilateral pul-
monary edema with effusions seen on chest radiographs.
Furosemide was started, but he subsequently developed
respiratory distress on the 12th postoperative day. An 8-
French pigtail catheter was emergently placed in the right
lower quadrant to improve the ascites, which immediately
drained chylous fluid with a triglyceride level of 461 mg/dL.
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for uric acid of 15.7 mg/dL, potassium of 5.4 mEq/L, phos-
phorous of 4.9 mg/dL, BUN of 64 mg/dL, and Cr of 2.65 mg/dL.
Rasburicase was started for suspected tumor lysis syndrome.
On postoperative day 15, the patient experienced asymp-
tomatic oxygen desaturation and was intubated. Emergent
hemodialysis was started for severe volume overload, but he
went into cardiac arrest and expired.Discussion
Tumor lysis syndrome refers to a metabolic dysregulation
caused by the rapid breakdown of malignant cells. It is most
commonly seen after the initiation of chemotherapy for
highly proliferative lymphomas and leukemias [7]. The pre-
cipitous destruction of neoplastic cells leads to an uncon-
trolled release of intracellular contents, causing
hyperuricemia, hyperkalemia, hyperphosphatemia, hypocal-
cemia, and acute renal failure [7].
In our case, we hypothesize that acute tumor lysis syn-
drome occurred after proximal splenic artery embolization
with consequent infarction of splenic tissue with significant
neoplastic invasion. Based on the CairoeBishop definition of
tumor lysis syndrome after chemotherapy [7], only hyper-
kalemia (7.8 mEq/L) was met within 3 days before to 7 days
after proximal splenic artery embolization. There was a >25%
increase of baseline inorganic phosphorous (1.5-3.8 mg/dL),
but this was after supplemental phosphate infusions. Acute
renal failure (BUN: Cr < 20:1) was noted 2 days after the pro-
cedure; however, Cr (1.58 mg/dL) was less than the Cairoe-
Bishop parameter. Contrast-induced renal injury remains a
probable cause. Nonetheless, the parameter for tumor lysis
syndrome was fulfilled 13 days after the procedure: hyper-
uricemia (15.7 mg/dL), hyperphosphatemia (4.9 mg/dL), and
increased Cr (2.65 mg/dL). The delayed onset of tumor lysis
syndrome may be due to a slower progression of tumor lysis
syndrome after splenic artery embolization versus tumor lysis
syndrome after chemotherapy.
It is also possible that proximal splenic artery embolization
precipitated a spontaneous form of tumor lysis syndrome.
Spontaneous tumor lysis syndrome, defined as tumor lysis
syndrome in the absence of cytotoxic therapy, is exceedingly
rare but occurs most commonly in hematologic malignancies
[8,9]. The low incidence of splenic infarction associated with
proximal splenic artery embolization, and the absence of
splenic infarction on surgical pathology support this claim.
However, hyperphosphatemia is less common in sponta-
neous splenic artery embolization, as is hypocalcemia [9]. The
phosphate released in spontaneous tumor lysis syndrome is
reused by dividing neoplastic cells rather than binding with
extracellular calcium [9].
Only one previous case of tumor lysis syndrome after
splenic artery embolization is known. Leibowitz et al [10]report a case of tumor lysis syndrome in a patient with
chronic lymphocytic leukemia about 3 hours after splenic
artery embolization, presenting as hyperkalemia with cardiac
arrhythmia during laparoscopic splenectomy. Similar to our
case, the patient had massive splenomegaly with malignant
involvement. However, proximal embolization was per-
formed in our case.
In summary, our case represents the second reported
incident of acute tumor lysis syndrome after splenic artery
embolization. Tumor lysis syndrome should be especially
considered after proximal or distal splenic artery emboliza-
tion in patients with advanced hematologic malignancies.
Potassium, phosphorous, calcium, and uric acid should be
monitored closely. Any abnormalities should be managed
promptly, and fluids and allopurinol should be given liberally
to avoid renal injury. At last, same day splenectomy and
embolization should be considered to decrease the likelihood
of developing tumor lysis syndrome.r e f e r e n c e s
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